The Annual Meeting was held on Thursday, May 5, 2022 at 11:30 a.m. (EDT). Original Source On May 4, 2022
May 27, 2022 Business News U.S. Food and Drug Administration Approves Two Opdivo® (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma